Atlas Trials

A Study to testABI-009 in Patients With Metastatic, Unresectable, Low or Intermediate Grade Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System

Clinical trial NCT03670030 · TERMINATED

Trial details

NCT number
NCT03670030
Sponsor
Robert Ramirez
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2018-11-05
Primary completion
2021-01-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.